Serum Institute Of India(Search results - 10)
India24, Oct 2020, 11:03 AM
Coronavirus: Bharat Biotech plans to release COVID-19 vaccine Covaxin by June 2021
The approval for late-stage clinical trial puts the Hyderabad-based firm behind the Serum Institute of India (SII), which is in the process of recruiting and vaccinating participants for the third phase of the clinical trial of its candidate, Covishield.
India29, Sep 2020, 3:45 PM
Coronavirus: Serum Institute of India to produce additional 100 million COVID-19 vaccine doses for India
The Serum Institute of India (SII) on Tuesday (September 29) said it would produce up to an additional 100 million COVID-19 vaccine doses for India in 2021.
India27, Sep 2020, 3:25 PM
Poonawalla to PM Modi: We share, applaud your vision on providing vaccines to global community
CEO of the Serum Institute of India, Adar Poonawalla has praised Prime Minister Narendra Modi and said that PM Narendra Modi's arrangements for India will take care of all the needs of the Indian people.
India16, Sep 2020, 8:57 AM
Coronavirus: SII gets DCGI nod to recommence clinical trials of Oxford COVID-19 vaccine
AstraZeneca had earlier paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness. It was reported that the clinical trial had been put on hold in the US, UK, Brazil and South Africa.
India12, Sep 2020, 12:43 PM
Coronavirus: DCGI orders SII to suspend new recruitment for Oxford's COVID-19 vaccine trials
The Drugs Controller General Of India (DCGI) has also directed the Serum Institute of India (SII) to increase the safety monitoring of the subjects who have already been vaccinated as part of the trial and submit the plan and report.
India10, Sep 2020, 11:40 AM
SII says ‘will abide by DCGI instructions’ after drug regulator issues notice over continuing vaccine trial
The DCGI issued a show-cause notice to Serum Institute of India (SII) seeking an explanation as to why the ongoing clinical trial of Covishield vaccine has not been paused in India.
India23, Aug 2020, 4:05 PM
Coronavirus: SII dismisses media reports over availability of COVID-19 vaccine in 73 days
Covishield will be commercialised only after trials are proven successful and all the requisite regulatory approvals are in place.
WORLD7, Aug 2020, 4:07 PM
Coronavirus: Serum Institute signs deal with Bill Gates to produce 100 million doses of COVID-19 vaccine
In a move that will bolster the attempts of coronavirus vaccine development and delivery to India and other countries, the Serum Institute of India has joined hands with Gavi, the Vaccine Alliance, and the Bill & Melinda Gates Foundation
India3, Aug 2020, 9:04 AM
Coronavirus: DCGI nod to Serum Institute of India for phase 2, 3 human trials of Oxford vaccine candidate
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa
India27, Jul 2020, 5:09 PM
Will keep ‘more than enough’ COVID-19 vaccine doses for Parsis: Serum Institute of India CEO
Replying to Ronnie Screwvala on Twitter, Poonawalla said, ‘Yes @RonnieScrewvala, we will keep more than enough for the community. Our production capacity of just one day will be enough to cover every Parsi on the planet. given the size of our community’